Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.09
-0.47 (-4.45%)
Oct 30, 2026, 11:45 AM EDT - Market open
Kura Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -296.78 | -278.67 | -173.98 | -152.63 | -135.84 | -130.47 |
Depreciation & Amortization | 1.29 | 1.03 | 0.85 | 0.85 | 0.76 | 0.56 |
Loss (Gain) From Sale of Investments | -4.95 | -8.49 | -13.14 | -9.42 | 1.61 | 4.39 |
Stock-Based Compensation | 38.94 | 37.11 | 33.9 | 28.08 | 26.32 | 23.58 |
Other Operating Activities | 0.46 | 0.52 | 0.52 | 0.48 | 0.07 | 0.61 |
Change in Accounts Receivable | -4.87 | -6.74 | -2.06 | - | - | - |
Change in Inventory | -2.49 | -0.41 | - | - | - | - |
Change in Accounts Payable | 1.64 | 4.5 | -1.63 | -0.92 | -0.8 | -2.52 |
Change in Unearned Revenue | 152.15 | 195.72 | 278.18 | - | - | - |
Change in Other Net Operating Assets | 2.84 | -8.62 | 11.68 | 8.74 | -2.18 | -0.71 |
Operating Cash Flow | -111.76 | -64.06 | 134.32 | -124.82 | -110.06 | -104.55 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -5.67 | -6.64 | -0.47 | -0.17 | -0.63 | -1.15 |
Investment in Securities | 103.02 | -6.46 | -101.12 | 15.73 | 33.25 | -125.69 |
Investing Cash Flow | 97.35 | -13.1 | -101.59 | 15.56 | 32.63 | -126.84 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | 10 | - |
Long-Term Debt Repaid | - | - | - | - | - | -7.25 |
Net Debt Issued (Repaid) | - | - | - | - | 10 | -7.25 |
Issuance of Common Stock | 2.7 | 1.79 | 154.42 | 94.78 | 29.14 | 4.43 |
Other Financing Activities | - | - | - | - | -0.58 | -0.61 |
Financing Cash Flow | 2.7 | 1.79 | 154.42 | 94.78 | 38.57 | -3.44 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -11.71 | -75.36 | 187.14 | -14.48 | -38.87 | -234.82 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -117.43 | -70.7 | 133.85 | -124.99 | -110.69 | -105.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -152.06% | -104.76% | 248.40% | - | - | - |
Free Cash Flow Per Share | -1.33 | -0.81 | 1.55 | -1.71 | -1.65 | -1.59 |
Levered Free Cash Flow | -165.88 | -141.73 | -55.93 | -63.9 | -63.67 | -60.41 |
Unlevered Free Cash Flow | -164.99 | -140.78 | -54.92 | -62.93 | -63.53 | -60.15 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1 | 1 | 1.1 | 1.06 | 0.07 | 0.78 |
Change in Working Capital | 149.27 | 184.44 | 286.17 | 7.82 | -2.98 | -3.22 |